Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of Repeated Dose 13-valent Pneumococcal Conjugate Vaccine Compared to the Existing Recommended Protocol of Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients

NCT01781871 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT01781871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01781871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of Repeated Dose 13-valent Pneumococcal Conjugate Vaccine Compared to the Existing Recommended Protocol of Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients
Lead sponsor
Helsinki University Central Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
October 4, 2017
Enrollment
182 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation, liver transplantation